These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 28922018

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study.
    Duque MI, Yosipovitch G, Fleischer AB, Willard J, Freedman BI.
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):519-21. PubMed ID: 15761435
    [Abstract] [Full Text] [Related]

  • 23. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis.
    Kymionis GD, Goldman D, Ide T, Yoo SH.
    Cornea; 2008 Feb; 27(2):228-9. PubMed ID: 18216583
    [Abstract] [Full Text] [Related]

  • 24. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P, Tesavibul N, Mahawong W.
    Cornea; 2012 Dec; 31(12):1386-93. PubMed ID: 23135530
    [Abstract] [Full Text] [Related]

  • 25. Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD).
    Cuevas M, González-García MJ, Castellanos E, Quispaya R, Parra Pde L, Fernández I, Calonge M.
    Curr Eye Res; 2012 Oct; 37(10):855-63. PubMed ID: 22632103
    [Abstract] [Full Text] [Related]

  • 26. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY, Liu HY, Chu HS, Chen WL, Hu FR, Wang IJ.
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [Abstract] [Full Text] [Related]

  • 27. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
    Attas-Fox L, Barkana Y, Iskhakov V, Rayvich S, Gerber Y, Morad Y, Avni I, Zadok D.
    Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
    [Abstract] [Full Text] [Related]

  • 28. [Efficacy of tracrolimus 0.1% ointment in prurigo].
    Lee HH, Sterry W, Worm M.
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):690-4. PubMed ID: 16173976
    [Abstract] [Full Text] [Related]

  • 29. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA, Lamerson C, Sheehan MP, Boguniewicz M, Mosser J, Raimer S, Shull T, Jaracz E, US Tacrolimus Ointment Study Group.
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical treatment of dry eye using 0.03% tacrolimus eye drops.
    Moscovici BK, Holzchuh R, Chiacchio BB, Santo RM, Shimazaki J, Hida RY.
    Cornea; 2012 Aug; 31(8):945-9. PubMed ID: 22511024
    [Abstract] [Full Text] [Related]

  • 33. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S, Ortonne JP, Sand C, Cambazard F, Bieber T, Fölster-Holst R, Vena G, Bos JD, Fabbri P, Groenhoej Larsen C, European Tacrolimus Ointment Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH, Kim JM, Laddha PM, Chung ES, Chung TY.
    Korean J Ophthalmol; 2012 Aug; 26(4):241-7. PubMed ID: 22870021
    [Abstract] [Full Text] [Related]

  • 35. A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.
    Abud TB, Amparo F, Saboo US, Di Zazzo A, Dohlman TH, Ciolino JB, Hamrah P, Dana R.
    Ophthalmology; 2016 Jul; 123(7):1449-57. PubMed ID: 27086024
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A, Reitamo S, Girolomoni G, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group.
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [Abstract] [Full Text] [Related]

  • 40. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM.
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.